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ABSTRACT 
The overall aim of this thesis was to investigate how modifiable lifestyle factors, with a focus 
on alcohol consumption and physical activity, influence the risk of atrial fibrillation (AF). 
The thesis is based on data from two prospective cohort studies of Swedish men (Cohort of 
Swedish Men) and women (Swedish Mammography Cohort). During 1997, 48,850 men who 
were born between 1918 and 1952 and lived in Västmanland and Örebro counties and 39,227 
women who were born between 1914 and 1948 and lived in Västmanland and Uppsala 
counties completed a questionnaire about lifestyle and other risk factors for chronic diseases. 
Information was also gathered from Swedish Inpatient Register, Cancer Registry, Death 
Registry, and Diabetes Register. 
In paper I, we examined the association between alcohol consumption and AF risk in a 
prospective study of Swedish men and women (n= 79,019) and conducted a meta-analysis of 
prospective studies (n =7). Alcohol consumption was associated with increased risk of AF in 
the two Swedish cohorts and in the meta-analysis of all studies. Even moderate intake was 
associated with increased risk of AF. 
In paper II, we investigated the association of physical activity, at different ages and of 
different types, with risk of AF in a large (n = 48,850) general male population. High level of 
leisure-time exercise (moderate-intensity to high-intensity physical activity) in younger men 
was associated with an increased risk of AF later in life. On the other hand, walking/bicycling 
(low- intensity to moderate-intensity) at an older age was associated with a reduced AF risk.  
In paper III, we evaluated the association between physical activity, at different ages and of 
different types, with risk of developing AF in a large (n = 39,227) general female population. 
Regular physical activity was associated with a reduced risk of AF in women. Moderate 
amount of daily physical activity was sufficient to have a significant risk reduction in middle-
aged and elderly women. High levels of leisure-time exercise (moderate-intensity to high-
intensity physical activity) were not a risk factor for AF in women as previously described in 
men.  
In paper IV we investigated the joint association of four modifiable lifestyle factors (alcohol 
consumption, body mass index, regular exercise and smoking) on incidence of AF in both 
men and women. The combination of adopting four healthy lifestyle factors was associated 
with a halving of the risk of AF. 
In conclusion alcohol consumption was associated with an increased risk of AF. A high level 
of intense physical activity may increase the risk of AF in younger men while low-moderate 
intense physical activity seems to decrease the risk in both men and women. High levels of 
intense physical activity were not a risk factor for AF in women.  Adopting a healthy lifestyle 
may significantly reduce the risk of AF in both men and women. AF may partly be 
preventable through modifiable lifestyle behaviors. Our findings underscore the importance 
of avoidance of an unhealthy lifestyle. 
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1 INTRODUCTION 
In the last decade, there has been an explosion of research in the field of AF. In the PubMed 
database through December 2016 more than 29,000 articles had AF in their title and more 
than 5,000 were published during the last two years. The extensive progress of the past 
decade has been made in understanding the pathophysiology, in developing new treatment 
options and in reducing the risk of thromboembolic complications but despite all the progress 
there remains a considerable need for improvement in the management of AF. 
The aim of the studies in this thesis was to focus on modifiable lifestyle factors that could 
influence the risk of AF and which could be used to improve the management of AF. 
1.1 DEFINITION 
According to the 2010 ESC Guidelines for the management of AF is defined as a cardiac 
arrhythmia with the following three characteristics [1]:  
(1) The surface ECG shows ‘absolutely’ irregular RR intervals (AF is therefore sometimes 
known as arrhythmia absoluta), i.e. RR intervals that do not follow a repetitive pattern. 
(2) There are no distinct P waves on the surface ECG. Some apparently regular atrial 
electrical activity may be seen in some ECG leads, most often in lead V1.  
(3) The atrial cycle length (when visible), i.e. the interval between two atrial activations, is 
usually variable and <200 milliseconds (>300 beats per minute). 
There is an agreement that at least a 30 second long episode of the above described 
arrhythmia is diagnostic for an episode of AF [2]. 
In the four studies included in this thesis the outcome of AF was defined as either a diagnosis 
of AF or of atrial flutter because of these two arrhythmias close interrelationship and the 
difficulties differentiating between these conditions [3, 4].  
AF has traditionally been classified in 5 different categories based on their presentation, 
clinical duration and spontaneous termination; First diagnosed AF, paroxysmal AF, persistent 
AF, long-standing persistent AF and permanent AF [5]. See Table 1 adopted from 2016 ESC 
Guidelines for the management of AF developed in collaboration with EACTS. The natural 
course of AF is that it usually progresses from short attacks of paroxysmal AF to more 
sustained attacks of persistent AF and eventually to permanent AF. Only a minor portion (2-3 
%) of AF patients will continue to stay in the paroxysmal group during the following several 
decades [1]. Treatment could also change the pattern of AF from persistent to paroxysmal 
and a patient could have attacks of both paroxysmal and persistent AF. 
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TABLE 1. CLASSIFICATION OF ATRIAL FIBRILLATION 
AF CLASSIFICATION Definition 
FIRST DIAGNOSED AF AF that has not been diagnosed before, irrespective of the duration of 
the arrhythmia or the presence and severity of AF-related symptoms. 
PAROXYSMAL AF Self-terminating, in most cases within 48 hours. Some AF paroxysms 
may continue for up to 7 days.  AF episodes that are cardioverted 
within 7 days should be considered paroxysmal. 
PERSISTENT AF AF that lasts longer than 7 days, including episodes that are terminated 
by cardioversion, either with drugs or by direct current cardioversion, 
after 7 days or more. 
LONG-STANDING 
PERSISTENT AF 
Continuous AF lasting for ≥1 year when it is decided to adopt a rhythm 
control strategy. 
PERMANENT AF AF that is accepted by the patient (and physician). Hence, rhythm 
control interventions are, by definition, not pursued in patients with 
permanent AF. Should a rhythm control strategy be adopted, the 
arrhythmia would be re-classified as ‘long-standing definition, not 
pursued in patients with permanent persistent AF’. 
 
Classification into these categories based on the duration of the AF episode has some clinical 
relevance since it has been shown that outcome of therapy such as catheter ablation is 
associated with the AF episode duration. There is better outcome in paroxysmal than in long-
standing persistent AF following catheter ablation [6]. 
Unfortunately, this classification does not consider mechanistic factors and modifiable risk 
factors for AF which precludes the implementation of an individual treatment strategy for 
each patient. In recent years, there have been attempts to introduce a new classification based 
on major causes or mechanistic factors for AF. Examples of such factors are atrial fibrosis, 
fatty or inflammatory infiltration in the atrial tissue, ion-channel dysfunction and autonomic 
imbalance of the nervous system. A classification that takes into account mechanistic factors 
and major risk factors for AF will assist in the formulation of more individual treatment 
strategies and hopefully also population based prevention strategies [7, 8].  
 
 8 
1.2 EPIDEMIOLOGY 
AF is the most common arrhythmia of clinical significance. The prevalence of AF is 
estimated in recent studies to be around 3 % among adults age 20 years or older [9, 10]. The 
prevalence of AF rises with increasing age. It is uncommon in younger age with prevalence  
< 0.2 % in people < 35 years but becomes a common medical condition in older age with a 
prevalence over 14 % in those older than 80-85 years [9-11].  The incidence and prevalence 
of AF is higher in men than in women in all age intervals. The increase of AF prevalence in 
recent studies compared to older studies is probably attributed to better diagnostics, an aging 
population and that older studies mostly included patients with permanent AF.  
1.3 SYMPTOMS AND PROGNOSIS 
AF can give a wide variety of symptoms such as general fatigue, rapid and irregular 
heartbeat, dizziness, shortness of breath, anxiety, weakness, faintness or confusion, decreased 
exercise tolerance, sweating and chest pain.  The symptom severity may vary from being 
totally asymptomatic to highly symptomatic affecting the person’s everyday life. 
Asymptomatic episodes of AF are common even in patients who have symptoms of AF. 
Since 2007 there is a classification of symptoms based on the impact on the patient’s daily 
activity during presumed episodes of AF. The classification is called the EHRA symptom 
scale and has been validated and widely used. In 2014 a modified version was proposed and 
also recommended by the ESC to be used for treatment decision and in research studies 
(Table 2) [5, 12].  
Table 2. Modified EHRA symptom scale 
Modified EHRA score Symptoms Description 
1 None AF does not cause any symptoms. 
2a Mild 
Normal daily activity not affected by 
symptoms related to AF. 
2b Moderate 
Normal daily activity not affected by 
symptoms related to AF, but patient troubled 
by symptoms. 
3 Severe 
Normal daily activity affected by symptoms 
related to AF. 
4 Disabling Normal daily activity discontinued. 
 
An EHRA symptom score of 2b is at present regarded to be the appropriate treatment 
threshold for intervention such as catheter ablation.  
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1.3.1 Stroke risk in atrial fibrillation 
AF is an independent risk factor for stroke. The risk is 4 to 5 times higher compared with 
persons without AF. In the presence of mitral stenosis the risk is further increased up to 20 
times  [13].  Patients with asymptomatic, paroxysmal,  persistent and permanent AF all have 
an increased risk for stroke but it seems that patients with persistent and permanent AF have a 
slightly higher risk for thrombo-embolic event (stroke or systemic embolism) and all-cause 
mortality compared with patients with paroxysmal AF [14, 15]. The risk of stroke in patients 
with non-valvular AF varies among patients depending on several risk factors. Clinically 
applicable stroke risk schemes have been developed and are still being refined. Today 
European and US guidelines advocate the use of the CHA2DS2-VASc score for estimating 
stroke risk in AF patients and for guidance off oral anticoagulant treatment [5, 16]. Points are 
given for different risk factors. One point each for the presence of congestive heart failure, 
hypertension, diabetes mellitus, vascular disease, age 65–74 years and female gender, and 
two points for age ≥75 years and previous stroke or TIA. The stroke risk increases with 
higher points. Patients without any of the afore mentioned risk factors and a score of zero are 
not recommended anticoagulant treatment. In male patients with a score of 1 point and in 
female patients with 2 points oral anticoagulant treatment should be considered while it is a 
clear indication in a male patient with 2 points and a female patient with 3 points [5]. 
1.3.2 Mortality and morbidity 
AF doubles the risk of all-cause mortality in women and increases the risk in men by about 
50% [17, 18]. AF triples the risk for heart failure and doubles the risk for dementia [19-21].  
The associations between dementia and AF could partially be explained by the increased risk 
of clinical stroke, but other mechanisms, including silent cerebral infarcts, microbleeds, and 
cerebral hypoperfusion, could be additional contributors [22]. Despite evidence based therapy 
there is still a considerably high morbidity and mortality.  
1.4 RISK FACTORS AND ASSOCIATED MEDICAL CONDITIONS 
The vast majority of published scientific papers during the last decades have been orientated 
in treatment of AF and prevention of stroke. Comparably little attention has been focused on 
prevention of AF. Several risk factors and associated medical condition linked to AF have 
been identified.  
Age is a major predictor of AF. Both incidence rate and prevalence rise with increasing age in 
both men and women [10] (Figure 1).  
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Figure 1. Prevalence of diagnosed AF in relation to age on 31 December 2010 in Sweden 
 
Reprinted from Journal of Internal Medicine reference [10] with permission from John 
Wiley & Sons. Copyright © 1999 - 2016 John Wiley & Sons, Inc. All Rights Reserved 
 
Male sex is an independent risk factor for AF and is associated with a 1.5-fold higher risk 
compared to women. Women with AF having similar stroke risk factors as men have 
however greater risk of having a stroke and maybe even a higher risk of death [18]. Adult 
height has also been observed to be strongly positively associated with AF in observational 
studies [23, 24]. None of the above mentioned risk factors are modifiable. Obesity and 
hypertension are the two modifiable factors that carry the largest population-attributable risks 
[25].  There are several others risk factors and medical conditions associated with AF; heart 
failure, valvular heart disease, myocardial infarction, chronic obstructive pulmonary disease, 
obstructive sleep apnea, chronic kidney disease, thyroid dysfunction, smoking and genetic 
predisposition.  
It is important to identify modifiable risk factor to decrease the burden of AF and devise 
improved management strategies. AF prevalence is increasing worldwide due to an ageing 
population and increasing prevalence of causative risk factors of AF. The health cost driven 
by complications of AF, such as stroke, and treatment cost will rise dramatically unless better 
prevention strategies are developed. In this thesis, we will focus on the modifiable risk factors 
alcohol consumption and physical activity and their association with AF. 
1.4.1 Alcohol 
Alcohol is a toxic substance that has deleterious effects on health. Liver cirrhosis is probably 
the best known but it can cause a wide variety of conditions such as dementia, breast cancer,  
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colorectal cancer, upper digestive tract cancer, injuries and accidents, and alcohol 
dependency [26]. Dilated cardiomyopathy is associated with heavy consumption over an 
extended period [27]. Alcohol consumption is one of the top contributors to the global burden 
of death and disability. It is estimated that alcohol attributes to the global burden of death 
with 3.8 % and with 4.6% to the global disability-adjusted life-years [28]. Despite that, the 
general media and the public have in the last decades focused on the positive effects of 
alcohol and in particular on positive effects on IHD. There are indications from 
epidemiologic studies that low to moderate alcohol consumption (<30g/day) may decreases 
the risk of IHD and ischemic stroke. Women appears to have a larger positive effect with low 
consumption but it transforms to a harmful effect at a lower level of average alcohol 
consumption compared to men [29]. Drinking pattern is important and episodic heavy 
drinking has not shown to be protective for IHD [30].   
Already in the early 70´s an association between acute alcohol consumption and cardiac 
arrhythmia was observed. The term "Holiday heart syndrome" was coined by Philip Ettinger 
1978 when he described an association between cardiac arrhythmia most frequently AF after 
binge drinking in otherwise healthy people. The name "Holiday heart syndrome" comes from 
the observation that the arrhythmia episodes were observed after weekends or public holidays 
[31].  
A standard drink is equivalent to 12 g of alcohol. This amount corresponds approximately to 
4 cl liquor, 8 cl strong wine, 15 cl wine, 33 cl class III beer (alcohol by volume, >3.5%), 50 
cl class II beer (2.8−3.5%), or 66 cl class I beer (<2.25%). Binge drinking is the 
consumption of ≥5 drinks per occasion. High alcohol consumption is the consumption of 
>60g per day in men and >40 g per day in women, moderate alcohol consumption is 20–60g 
per day in men and 10–40g per day in women and light drinking relates to <20g per day in 
men and <10g per day in women [32]. 
Consuming moderate to high amounts of alcohol on a regular basis may increase the risk of 
developing AF [33-37]. However, the association between light and moderate drinking and 
incident AF is less well studied. 
1.4.2 Physical activity 
The definition of physical activity is any bodily movement produced by skeletal muscles that 
result in energy expenditure. Exercise is defined as a subcategory of physical activity that is 
planned, structured and has a purpose of improving or maintaining physical fitness [38].  
The gold standard for measurements of free-living total energy expenditure is the doubly-
labeled water method [39]. Doubly labeled water is an excellent method to measure total 
energy expenditure in humans over a period of 1–4 weeks. The limitation is that it is 
expensive, unsuitable for large population studies and does not provide information of type 
and intensity. There are several other techniques to measure or estimate physical activity. 
There is behavioral observation, questionnaires (including diaries, recall questionnaires and 
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interviews) and physiological markers like heart rate monitoring and different kinds of 
sensors for motion.  
When it comes to measure physical activity in a large population sample over a long period 
there is no golden standard. Self-reported physical activity questionnaires are the most 
common method for assessment of physical activity in large epidemiological studies. It is 
cheap, and relatively easy to administrate to a large study population. The drawback is lower 
reliability and validity and it is probably best used as an activity-ranking instrument [40]. 
Physical activity is a modifiable health related factor that contributes to the prevention and 
management of different medical conditions and diseases. Regular physical activity is 
associated with a lower risk for important medical conditions such as cardiovascular disease, 
cerebrovascular disease, hypertension, obesity, DM, osteoporosis, some malignancies, and 
mental illness [41-45].  
The American College of Sports Medicine and the Centers for Disease Control and 
Prevention published 1995 national guidelines for physical activity. A minimum of 30 min of 
moderate-intensity physical activity was recommended most days a week. An updated 
recommendation came in 2007 which clarified the recommended frequency for moderate-
intensity and furthermore, recommendation for vigorous intensity physical activity was 
incorporated. The 2007 recommendation for an adult is a minimum of moderate-intensity 
physical activity for 30 min on five days per week or vigorous-intensity aerobic physical 
activity for a minimum of 20 min on three days per week. Combinations of moderate- and 
vigorous-intensity activity can be performed to meet this recommendation [46]. There is a 
dose-response relation between physical activity and health and for the majority of health 
outcomes better outcomes will occur with higher intensity, longer duration and greater 
frequency [47] (Figure 2). 
However, some studies raised the doubt that exercise may be associated with higher 
incidence of AF. Several small case-control studies reported that long-term regular sport 
activity was associated with higher risk of AF in young and middle-aged men[24, 48-51]. On 
the other hand, a prospective study of older men and women observed a reduction in risk of 
AF with moderate-intensity physical activity and no increase in risk with more intense 
physical activity[52]. It seems that there was a more complex association between physical 
activity and AF and that the association could be J or U-shaped. Furthermore, studies in 
women were scarce and very few studies included women.  
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Figure 2. Daily physical activity duration and all-cause mortality reduction in a cohort of       
416,175 individuals aged 20 years with an average follow-up of 8.05 years.  
 
Reprinted from The Lancet, reference [47] with permission from Elsevier.  
1.4.3 Other modifiable risk factors 
Obesity (BMI ≥30 kg/m2) is a growing problem worldwide. According to the WHO, the 
worldwide prevalence of obesity has doubled since 1980. In 2014 it was estimated that about 
13% of the world’s adult population were obese and 39 % overweight (BMI≥25 kg/m2). 
Several cohort and case-control studies have shown that obesity and overweight are 
associated with an increased risk of AF [53]. The Framingham Heart Study observed a 4% 
increase in risk of AF per 1-unit increase in BMI for both men and women in a multivariable-
adjusted model [54]. A recent meta-analysis also highlighted that obesity is a risk factor for 
having AF after surgery or relapsing in AF after catheter based ablation of AF [53]. The 
Women´s Health Study demonstrated that women who lost weight during the study period 
decreased their risk of AF while the opposite happened to women who gained weight [55]. 
This concept of decreasing AF burden and symptom severity with weight reduction was also 
observed in the prospective LEGACY study [56]. They observed that sustained weight loss, 
particularly with avoidance of weight fluctuation, was associated with a dose-dependent 
reduction in AF burden and maintenance of sinus rhythm. 
Hypertension is a risk factor both for AF and stroke and a good blood pressure control is 
crucial [57]. Antihypertensive drugs reduce the risk for AF mainly by lowering blood 
pressure [58]. It has been suggested that specific antihypertensive medication could have 
additional effects. Some studies have suggested that blockade of the renin–angiotensin 
system with angiotensin-converting enzyme inhibitors or an angiotensin receptor blockers  
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could decrease the risk of AF through atrial remodeling [59]. There are studies showing that 
beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers 
could reduce the risk for AF compared with calcium-channel blockers in patients with 
hypertension [60, 61].  
Smoking is an established cardiovascular risk factor and the leading preventable cause of 
premature disease and death [62]. Several studies have shown smoking to be a risk factor for 
AF while others have been unable to show any association [20, 63-66]. A recent meta-
analysis of 16 prospective cohort studies showed that smoking is associated with a modest 
increased risk of incident AF [67].  There are no randomized trials proving that smoking 
cessation reduces the risk of AF. Health care professionals should encourage individuals to 
quit smoking to reduce disease and prevent premature death. 
DM is an independent risk factor for AF and the risk for AF increase with longer duration 
and worse glycemic control [57, 68]. In the ARREST-AF trial a strategy of aggressive risk 
factor modification on multiple risk factors including weight loss and improved glycemic 
control reduced the risk of recurrent AF after catheter ablation [69]. In the ACCORD trial an 
intensive glycemic control targeting a glycated hemoglobin level of <6.0% compared to 
standard strategy targeting a glycated hemoglobin of 7.0-7.9% was not able to reduce the risk 
for new onset AF in DM patients [70]. 
Obstructive sleep apnea, has been associated with an increased risk of AF [71, 72].  
Treatment of sleep apnea with continuous positive airway pressure reduces the risk of 
relapsing in AF in patients undergoing catheter ablation with pulmonary vein isolation, after 
electrical cardioversion and in patients who were managed medically [73, 74]. Obesity and 
being overweight is associated with sleep apnea and weight reduction reduces the severity of 
sleep apnea and AF [56, 75]. 
1.5 MANAGEMENT AND TREATMENT  
Generally, there are three aspects in the management of atrial fibrillation.  
1) Stroke prevention 
2) Manage risk factors and underlying cardiovascular conditions 
3) Reset the rhythm or control the rate 
1.5.1 Stroke prevention 
Stroke prevention is the most important therapeutic goal in management of AF. OAC is 
recommended for stroke prevention and CHA2DS2-VASc score for estimating stroke risk in 
non-valvular AF. There are two types of OAC; warfarin (vitamin K antagonist) and NOACs 
(non-vitamin K antagonists). In a meta-analysis of 29 trials warfarin reduced the risk of 
stroke by 64% compared to controls (aspirin or no treatment)[76]. Since 2011 NOACs have 
been introduced as alternatives to warfarin for prevention of stroke in patients with non-
valvular AF and in the most recent guidelines from ESC NOACs are recommended in 
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preference to warfain when OACs are initiated in patients with AF who are eligible for 
NOACs. In patients with mechanical heart valves or moderate to severe mitral stenosis, 
warfarin is recommended and NOACs are not recommended [5]. 
 LAA is the primary source for embolus in AF specially in non-valvular AF and 90 % of 
emboli are considered to originate from LAA [77]. Exclusion or occlusion of the LAA has 
been used to reduce the stroke risk in AF patients. Both surgical and percutaneous device 
strategies are available for occlusion or exclusion. Currently only one device (Watchman®) 
has been compared with warfarin in randomized controlled trials. The Watchman®, a 
percutaneous closure device of the LAA, showed non-inferiority to warfarin treatment for 
prevention of stroke in AF patients with moderate risk of stroke. The Watchman® device is 
mainly used in patients with contraindication for OAC [78]. Surgical occlusion or exclusion 
in patients undergoing cardiac surgery has been done for many years but large randomized 
trials are not available to determine the effect in stroke prevention compared to OAC. 
1.5.2 Risk factor management and assessment of underlying cardiovascular 
condition 
When treating a patient with AF it is important to identify risk factors and underlying 
cardiovascular conditions to optimize treatment. Risk factors including obesity, hypertension, 
diabetes, obstructive sleep apnea, excessive alcohol consumption, smoking, sedentary 
lifestyle, that have been mentioned and discussed in previous chapters should be addressed. 
Underlying cardiovascular conditions including valvular heart disease, heart failure and 
elevated blood lipids should be diagnosed and treated. In the ARREST-AF cohort study 
aggressive risk factor management with a combination of blood pressure control, weight 
management with diet and exercise, lipid management, glycemic control, management of 
obstructive sleep apnea and support for smoking cessation and reduction in alcohol intake 
markedly improved the long-term success after AF ablation [69].   
1.5.3 Rhythm control or rate control 
The two treatment strategies to manage AF are rate control or rhythm control. Rhythm 
control is aimed at restoration and maintenance of sinus rhythm while rate control accepts the 
AF and the aim is to regulate the rate. The optimal heart rate in rate controlled AF patients is 
currently unclear. A ventricular rate of <80 beats per minute at rest and <115 beats per minute 
at moderate exercise is often recommended [79].  In the RACE II trial which was a 
randomized controlled trial with the intention to investigate if lenient rate control (resting 
heart rate <110 beats per minute) is not inferior to strict rate control (resting heart rate <80 
beats per minute) for preventing cardiovascular morbidity and mortality in patients with 
permanent AF it was noted that lenient rate control was non-inferior to more strict rate 
control. However, the actual rate difference between the two groups at the end of the first 
year of the study was not so large (86±15 in lenient group and 75±12 in strict group). In the 
European guidelines a lenient rate control is recommended as an initial approach, unless 
patient is highly symptomatic and requires a stricter rate control [5]. In the US guidelines a 
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more strict rate control (<80 beats per minute) is considered reasonable and a lenient rate 
control just in patient who remain asymptomatic and have a preserved left ventricular 
function [80]. Rate control could also be accomplished by AV-nodal ablation and permanent 
ventricular pacing. This approach is only recommended in patients after rate control with 
medication has been attempted and rhythm control is not possible.  Rhythm control could be 
achieved either with the help of antiarrhythmic drugs, electrical cardioversion, catheter 
ablation, surgical procedures (both surgical ablation and cut-and-sew technique) or a 
combination of these methods. Catheter ablation is a minimally invasive rhythm control 
procedure and surgical procedures are mainly done in patients undergoing cardiac surgery for 
indications other than AF [81]. Studies comparing rhythm control with antiarrythmic drugs 
versus rate control have not been able to show any survival benefit with rhythm control [82-
84]. Catheter ablation performed at experienced centers is more effective than antiarrythmic 
drugs in maintaining sinus rhythm and improves the quality of live [85-87]. It is still unclear 
if catheter ablation improves the long-time survival and reduces cardiovascular events but 
this is under investigation. Currently rhythm control is indicated for symptom improvement 
in AF patients.  
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2 AIMS OF THE THESIS 
The overall aim of this thesis was to investigate whether modifiable life style factors 
influence the risk of atrial fibrillation in a general population. 
The specific aims of the studies were to investigate: 
 
1. Whether alcohol consumption influences the risk of atrial fibrillation among men and 
women. 
 
2. The association between physical activity and risk of atrial fibrillation in a general 
population of men. 
 
3. The association between physical activity and risk of atrial fibrillation in a general 
population of women. 
 
4. The overall inpact of a combination of healthy lifestyle factors on the risk of atrial 
fibrillation.  
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3 METHODS 
3.1 STUDY POPULATION 
3.1.1 Swedish Mammography Cohort 
SMC is a population based cohort established between 1987 and 1990 when all women            
(n = 90,303) who lived in Uppsala and Västmanland counties and were born between 1914 
and 1948 received an invitation for a mammography screening program together with a diet 
and lifestyle questionnaire. In 1997 a second extended questionnaire was sent out to all 
women in the original cohort who were still alive (n = 56,030). The questionnaire in 1997 
included questions about physical activity, alcohol consumption, history of cigarette smoking, 
body weight across the life course, height and other questions about lifestyle and risk factors 
for chronic diseases. The response rate for the 1997 questionnaire was 70 % (n = 39,227). 
Information from the 1997 questionnaire was used for the exposure assessment in all studies 
in this thesis that included women (Study I, III and IV).  
3.1.2 Cohort of Swedish Men  
The population based COSM was established 1997 when all men (n=100,303) born between 
1918 and 1952 living in Västmanland and Örebro counties received an invitation to 
participate in the study along with a self-administered questionnaire. It was the same 
questionnaire used for the women in the SMC in 1997 except for some sex specific questions. 
Of the eligible men, 48,850 (49%) completed the questionnaire. Information from the 1997 
questionnaire was used for the exposure assessment in all studies in this thesis that included 
men (Study I, II and IV). 
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Figure 3. Source population, exclusions and study population for study I-IV 
 
 
3.2 NATIONAL HEALTH REGISTRIES 
3.2.1 The Swedish National Patient Register 
The Swedish NPR also called Hospital Discharge Register that started as a trial in 1964 has 
since 1987 full national coverage of all in-hospital specialist care of somatic and psychiatric 
care. The NPR contains information about both primary and secondary diagnosis coded 
according to the Swedish ICD system (adapted from WHO ICD classification system). Since 
2001 it also contains information from out-hospital specialist care. Since the start of the NPR, 
primary diagnoses are missing in only 0.8% of somatic care [88]. 
3.2.2 The Swedish Cancer Register 
The SCR was founded in 1958 and covers the whole population. All health care providers are 
obliged to report newly detected cancer cases to the registry. The most recent quality study 
for the SCR was published in 2009 and it was a sample survey from 1998 and it estimated the 
underreporting to be less than 4% [89]. 
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3.2.3 The Swedish Cause of Death Register 
Sweden has one of the oldest population statistics in the world. Already in 1749 a nationwide 
reporting system was developed. The priest in the parish was required to report causes of 
death in the population. The current Causes of Death Register contains information from 
1961. 93 % of all deaths are reported within 10 days and 100 % within 30 days. The cause of 
death in missing in 1-2 % [90]. 
3.2.4 Swedish National Diabetes Register 
The National Diabetes Register was initiated in 1996 as a registry to assure quality and 
support diabetic care. Trained nurses and physicians collect data during regular appointments 
at specialist clinics and primary healthcare centers nationwide and report at least once a year 
either online or by electronic transmission of patients’ charts. During the past 20 years, the 
coverage has grown and in 2015 the register covered 90 % of all adults with type II diabetes 
and its use in medical research has grown [91]. The coverage in 2009 was estimated to be 70 
%. 
3.3 ASSESSMENT OF EXPOSURE 
3.3.1 Alcohol (Paper I) 
Alcohol consumption was assessed in the self-administered questionnaire where participants 
reported their alcohol consumption status (never, former and current drinker of alcohol) and 
their average consumption of 96 foods and beverages, including 6 alcoholic beverages, 
during the past year. They reported how often they consumed class I beer (<2.25%, alcohol 
by volume), class II beer (2.8% to 3.5%), class III beer (>3.5%), wine, strong wine, and 
liquor as well as the amount they usually drank at each occasion. The amount of alcohol 
consumption at each occasion was asked in an open-ended question and for the frequency of 
consumption there were 9 pre-defined categories, ranging from never to ≥3 times per day. 
The questionnaire has been validated in a group of 248 men, and the Spearman correlation 
coefficients between estimates from the questionnaire, and the mean of 14 24-h recall 
interviews which were made during a period of one year was 0.81 for alcohol (ethanol) [92]. 
3.3.2 Physical activity (Paper II and III) 
Physical activity was assessed by a self-administered questionnaire. The participants reported 
their physical activity level at work (mostly sitting down; sitting down about half of the time; 
mostly standing up; mostly walking, lifts, carry little; mostly walking, lifts, carry much; 
heavy manual labor), walking/bicycling (almost never, <20 min per day, 20–40 min per day, 
40–60 min per day, 1–1.5 h per day, or >1.5 h per day), doing home/household work (<1, 1–
2, 3–4, 5–6, 7–8, or >8 h per day) and leisure-time exercise (<1, 1, 2–3, 4–5, or >5 h per 
week). The questionnaire also included questions about inactivity; watching TV/reading (<1, 
1–2, 3–4, 5–6, or >6 h per day) and an open question about hours per day sleeping or resting. 
In paper II and III we used information from physical activity levels on walking/bicycling 
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and leisure-time exercise. The participants were asked to assess their level of physical activity 
at current age (1997) and retrospectively at age 15, 30 and 50 years (Figure 4). 
Figure 4. Physical activity question on walking/bicycling and leisure-time exercise in the 
1997 questionnaire 
Mark your level of physical activity at different ages 
Walking/cycling 15 yrs 30 yrs 50 yrs this yr 
     
Hardly ever          
Less than 20 min/day          
20-40 minutes/day          
40-60 minutes/day          
1-1,5 hours/day          
More than 1,5 hours/day          
Leisure time     
     
Exercise 15 yrs 30 yrs 50 yrs this yr      
Less than 1 hour/week          
1 hours/week          
2-3 hours/week          
4-5 hours/week          
More than 5 hours/week          
          
 
The validity of the assessment of physical activity through the questionnaire used in the 
COSM was tested in 111 men, aged 44–78 years, by comparison with two 7-day activity 
records performed 6 months apart [93]. The Spearman correlation coefficients (adjusted for 
within-person and between-person variations in the records) between the questionnaire and 
activity records were 0.4 for combined walking/bicycling and exercise. It was also validated 
for women in the SMC using two 7-day activity records that were performed 12 months apart 
in 116 women (aged 56–75 years) randomly selected from the cohort [94]. Validity of 
combined exercise and walking/bicycling was 0.42; this was measured by deattenuated 
concordance correlations comparing the records with the questionnaire 
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3.3.3 Other lifestyle factors; Smoking and BMI (Paper IV) 
Smoking 
Smoking status was reported at baseline in the 1997 questionnaire. Participants reported their 
smoking status (never, past or current smoker) and smoking history throughout life. They 
were asked to report number of cigarettes per day at 15-20 years of age and then for every 
decade thereafter up to 60 years and at baseline in 1997.  One pack-year was defined as 20 
cigarettes per day for one year. There is no specific validation study on smoking status for the 
COSM or the SMC. Most studies have shown underreporting specially in groups where 
smoking is particularly undesirable such as pregnant women or individuals with smoking 
related disease [95].  
BMI 
Current weight in kilograms and height in centimeters at age 20 was reported at baseline in 
the 1997 questionnaire. Participants were asked to report their weight at 20 years of age and 
then for every decade thereafter up to 80 years. BMI was calculated using height at 20 years 
and weight at baseline in 1997. BMI was calculated by dividing weight (kg) with height 
squared (m2). Swedish men and women tend to overestimate their height and underestimate 
their weight [96]. High validity has been observed for self-reported height (r = 0.9) and 
weight (r = 0.9) compared with actual measurement [96]. 
Definition of healthy lifestyle in paper IV 
We analyzed four pre-specified modifiable lifestyle factors. BMI, regular exercise, alcohol 
consumption, and smoking. A healthy lifestyle score was created by dichotomizing each 
lifestyle factor into a predefined healthy lifestyle alternative and a less healthy behavior: BMI  
(<25 kg/m2 versus ≥25 kg/m2 [overweight]); regular exercise during the last year defined as 
walking or bicycling at least 20 min/day versus <20 min/day; alcohol consumption (no or 
light-to-moderate alcohol consumption [≤2 drinks/day for men and ≤1 drink/day for women] 
versus high consumption); and smoking (not smoking [never and past] versus current 
smoking). The allocated points of lifestyle factors were combined to create a healthy lifestyle 
score that ranged from 0 (no adherence to the healthy lifestyle) to 4 (full adherence). 
3.3.4 Comorbidities and other information 
Information about family history of myocardial infarction, history of hypertension, history of 
diabetes mellitus, history of coronary heart disease, education, and aspirin use was collected 
from the 1997 questionnaire. Information on coronary heart disease and heart failure was 
obtained from the Swedish NPR. Participants were classified as having diabetes if they self-
reported diabetes on the questionnaire or had a diagnosis of diabetes recorded in Swedish 
NPR or the Swedish NDR. 
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3.4 ASSESSMENT OF OUTCOME 
The outcome of AF was defined as either a diagnosis of AF or of atrial flutter because of their 
close interrelationship and the difficulties differentiating between these conditions. AF cases 
were identified by computerized linkage of the study cohort to the Swedish NPR using the 
Swedish Personal Identification Number. We used the codes 427.92 from ICD-8, 427D from 
ICD-9, and I48 (I48.0, I48.1, I48.2, I48.3, I48.4, I48.9) from ICD-10 to identify the diagnosis 
of AF and atrial flutter. 
3.5 FOLLOW UP-TIME 
Participants were followed up from January 1, 1998 until the date of diagnosis of AF, death 
(ascertained through linkage to the Swedish Death Register) or end of follow-up (December 
31, 2009), whichever occurred first. The median follow-up was 12 years (10th percentile 7.5 
years, 90th percentile 12.0 years). 
3.6 STATISTICAL ANALYSIS 
3.6.1 Statistical methods 
All the studies used Cox regression hazard models to estimate hazard ratios (referred to 
hereafter as relative risks [RR]) between exposure groups [97]. The time-scale used was the 
time-on-study time scale, defined as the time interval between the date of study entry and the 
date of study exit. Cox regression has the assumption that the ratio of the rates is constant 
during follow-up. We tested the proportional hazards assumption using the Schoenfeld 
residuals. We used the likelihood ratio test, comparing models with and without interaction 
terms, to assess statistical interaction. In paper I, the chi-square test we used for differences 
in associations for beverage types. 
All analyses were performed using the statistical software SAS (V.9.3; SAS Institute, Cary, 
North Carolina, USA) except for the meta-analysis in paper I where we used Stata (version 
12.0, StataCorp, College Station, Texas). All statistical tests were two-sided, and p values 
<0.05 were considered statistically significant. 
3.6.2 Missing values 
In all papers men and women with an erroneous or a missing PIN, those with a prior 
diagnosis of AF or cancer except non-melanoma skin cancer, and those who died between the 
administration of the questionnaire and start of follow-up were excluded. 
In paper I participants with missing data on alcohol consumption were excluded. 
In paper II and III if information about physical activity at baseline were missing, we used 
information for physical activity at age 50 years. Participants with missing data on leisure-
time exercise or walking/bicycling were excluded from the corresponding analysis. 
In paper IV we excluded men and women with missing data on any of the four lifestyle 
factors (BMI, walking/bicycling, alcohol consumption and smoking). 
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For detailed information see Figure 3. 
3.7 META-ANALYSIS (PAPER I)  
We performed a dose-response meta-analysis that included findings from the two Swedish 
prospective cohorts (COSM and SMC) and results from previously published; prospective 
studies to summarize the available data on the association between alcohol consumption and 
AF in paper I. 
3.7.1 Selection of Studies 
The PubMed database was used to identify relevant studies by a computerized search through 
January 10, 2014. We used the search terms alcohol consumption, alcohol drinking, or 
alcohol intake combined with AF or atrial flutter. Furthermore, we reviewed the reference 
lists of retrieved articles for further studies. No language restrictions were applied.  
Eligibility criteria for inclusion in the meta-analysis were: 1) prospective design; 2) the 
exposure was alcohol consumption; 3) the outcome was incidence of AF or AF and atrial 
flutter combined; and 4) RRs with 95% CIs were reported for at least 3 categories of alcohol 
consumption to be able to estimate a dose-response trend. When there were duplicate 
publications from the same source population, we included the study with the largest number 
of AF cases. We did not include studies of recurrence of AF. 
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4 RESULTS 
4.1 PAPER I: ALCOHOL CONSUMTION AND THE RISK OF AF  
Prospective cohort study of COSM and SMC. 
During a median follow-up of 12 years of 79,019 participants, including 43,841 men and 
35,178 women (859,420 person-years), we ascertained 7,245 incident AF cases (4,488 in men 
and 2,757 in women).  Baseline characteristics of the study population for the lowest and 
highest categories of alcohol consumption are shown in Table 3. 
The associations of alcohol drinking status and consumption of total alcohol and different 
alcoholic beverages with risk of AF are presented in Table 4. The association between 
alcohol consumption and AF did not differ by sex (p for interaction = 0.74). All analyses 
were therefore conducted for men and women combined. Compared with current alcohol 
drinkers of <1 drink per week, consumption of 15−21 drinks per week and >21 drinks per 
week was associated with a statistically significant 14% and 39%, respectively, increased risk 
of AF. 
Binge drinking (consumption of ≥5 drinks on a single occasion) was identified in 18% of 
current drinkers and was associated with an increased risk for AF after multivariable 
adjustment (age, sex, education, smoking, BMI, family history of MI, and histories of CHD, 
heart failure, diabetes, and hypertension) (RR: 1.13; 95% CI: 1.05-1.22). The association 
between binge drinking and AF was similar after further adjustment for frequency of 
consumption of each alcoholic beverage (RR: 1.12; 95% CI: 1.04-1.21) or for total alcohol 
consumption (drinks/week) (RR: 1.11; 95% CI: 1.03-1.20). Binge drinking of liquor (RR: 
1.10; 95% CI: 1.02-1.19) and wine (RR: 1.24; 95% CI: 1.08-1.43), but not beer (RR: 1.02; 
95% CI: 0.79-1.30), was associated with increased AF risk in a multivariable model adjusted 
for the other AF risk factors, mutually for liquor, wine, and beer, and for frequency of 
consumption of each alcoholic beverage. After excluding the binge drinkers, the association 
between total alcohol consumption and AF risk was slightly attenuated but still present; 
multivariable RRs (95% CI) were 1.11 (95% CI: 0.98 to 1.26) for 15 to 21 drinks/week and 
1.34 (95% CI: 1.17 to 1.53) for >21 drinks/week compared with current drinkers of <1 
drink/week. 
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Table 4. Relative risks (95% confidence intervals) of atrial fibrillation by alcohol drinking 
status and number of drinks of total alcohol, liquor, wine, and beer in current drinkers 
among 79,019 Swedish men and women 
Alkohol drinking 
status 
No. of 
Cases 
Person-
years 
Age-adjusted 
RR (95% CI) 
Multivariable 
RR (95% CI)* 
Multivariable 
RR (95% CI)*† 
      
  Never  820 66,101 1.02 (0.93-1.12) 1.02 (0.93-1.12) 1.07 (0.93-1.12) 
  Past  406 36,765 1.02 (0.91-1.14) 0.96 (0.85-1.08) 1.01 (0.89-1.16) 
  Current, drinks/wk‡      
    <1 (0.4)§  1,232 132,869 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    1-6 (4.6) 2,909 381,029 0.99 (0.92-1.06) 1.01 (0.92-1.06) 1.06 (0.98-1.15) 
    7-14 (10) 1,162 158,611 1.05 (0.96-1.14) 1.07 (0.98-1.17) 1.12 (1.01-1.23) 
    15-21 (16.6) 381 4, 969 1.15 (1.02-1.30) 1.14 (1.01-1.28) 1.18 (1.03-1.35) 
    >21 (28.4) 335 35,076 1.42 (1.25-1.62) 1.39 (1.22-1.58) 1.43 (1.25-1.65) 
    P for trend¶   <.0001 <.0001 <.0001 
Liquor, drinks/wk      
    <1 (0.1) 3,993 629,590 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    1-6 (2.3) 1,603 188,686 1.08 (1.02-1.15) 1.04 (0.97-1.11) 1.05 (0.97-1.12) 
    7-14 (8.8) 314 32,352 1.25 (1.11-1.41) 1.13 (1.01-1.28) 1.14 (1.00-1.30) 
    >14 (18.8) 109 8,792 1.69 (1.39-2.05) 1.43 (1.14-1.74) 1.46 (1.18-1.81) 
    P for trend¶   <.0001 0.0002 0.0002 
Wine, drinks/wk      
    <1 (0.2) 3,465 484,708 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    1-6 (2.6) 2,128 319,913 0.99 (0.93-1.04) 1.02 (0.96-1.07) 1.02 (0.96-1.09) 
    7-14 (8.6) 331 45,248 1.11 (0.99-1.24) 1.09 (0.97-1.23) 1.07 (0.94-1.21) 
    >14 (18.6) 95 9,551 1.37 (1.11-1.68) 1.30 (1.06-1.61) 1.35 (1.08-1.68) 
    P for trend   0.003 0.009 0.01 
Beer, drinks/wk      
    <1 (0.1) 2,954 443,987 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    1-6 (2.7) 2,196 303,557 0.95 (0.90-1.01) 0.96 (0.91-1.02) 1.00 (0.93-1.06) 
    7-14 (11.5) 584 72,041 1.09 (0.99-1.20) 1.07 (0.98-1.12) 1.11 (1.00-1.23) 
    >14 (21.2) 285 39,835 1.12 (0.98-1.27) 1.06 (0.93-1.23) 1.03 (0.87-1.19) 
    P for trend¶   0.02 0.14 0.28 
*Multivariable models were stratified by age (in months) and sex and adjusted for 
education (primary school, high school, university), smoking status and pack years of 
smoking (never smoker, past smoker and <20 pack-years, past smoker and ≥20 pack-years, 
current smoker and <20 pack-years, current smoker and ≥20 pack-years), body mass index 
(<23.0, 23.0-24.9, 25.0-29.9, ≥30 kg/m2), family history of myocardial infarction before 60 
years of age (yes/no), history of coronary heart disease or heart failure (yes/no), history of 
diabetes (yes/no), history of hypertension (yes/no), aspirin use (yes/no), exercise (5 
categories), and walking/bicycling (5 categories). 
†Excluding men and women with diagnosed coronary heart disease or heart failure at 
baseline. 
‡Standard drinks = 12 g alcohol. One standard drink corresponds to approximately 4 cl 
liquor, 8 cl strong wine, 15 cl wine, 33 cl class III beer (alcohol by volume, >3.5%), 50 cl 
class II beer (2.8−3.5%), or 66 cl class I beer (<2.25%). 
§Median values in parenthesis. 
¶P for trend across categories of alcohol consumption among current drinkers using the 
median consumption in each category as a continuous variable. 
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Dose-response meta-analysis 
Seven prospective studies, including the two Swedish cohort studies (COSM and SMC), were 
included in the meta-analysis (Figure 6). Combined these studies contributed 12,554 cases of 
AF. Three studies were conducted in the United States, 3 studies in Europe, and one study 
included participants from 40 countries. Alcohol consumption was assessed through a self-
administered questionnaire in 6 studies and through interviews in one study [35-37, 98-101] 
(Figure 5). 
Figure 5.  Flow chart of study selection. 
 
 
In a meta-analysis of all studies, we observed a linear dose-response relationship between 
alcohol consumption and AF risk. All studies reported a positive association, with an overall 
8% (6−10%) increase in AF risk for each 1 drink/day increase in alcohol consumption 
(Figure 6). Excluding our own study, which contributed 40% of the statistical weight, did not 
change the overall results (RR = 1.08; 95% CI: 1.05-1.10). 
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Figure 6. Forest Plot of RR of AF per 1 drink/day increment in alcohol consumption 
 
 
4.2 PAPER II: PHYSICAL ACTIVITY AND THE RISK OF AF IN MEN 
Participants were followed up between 1st January 1998 and 31st December 2009. During a 
median follow-up of 12 years, 4,568 cases of AF were identified in the cohort, which 
corresponds to 9.6 cases of AF per 1,000 person-years. Baseline characteristics of the study 
population for the lowest and highest categories of leisure-time exercise and 
walking/bicycling are shown in Table 5. 
After adjustment for other risk factors and excluding men with coronary heart disease or heart 
failure at baseline, we observed a positive association between leisure-time exercise (high-
moderate intensity physical activity) at age 30 and risk of AF. Men who engaged in exercise 
for five hours or more per week at age 30 had a 19% (95% CI: 5%-36%) higher risk of AF 
compared with men who engaged in exercise for less than one hour per week. 
Walking/bicycling (low-moderate intensity physical activity) at the age of 30 was not 
associated with risk of AF. However, walking/bicycling at baseline (mean age 60 years) was 
inversely associated with risk of AF (RR 0.87; 95% CI: 0.77 to 0.97 for >1 h/day vs almost 
never) and the association was similar after excluding men with previous coronary heart 
disease or heart failure at baseline (Table 6). To investigate how the amount of leisure-time 
exercise throughout life influences the risk of developing AF, we categorized the population 
into five groups: Group 1 (reference group): exercise <1 h/week at age 30 and at baseline; 
Group 2: exercise >5 h/week at age 30 and <1 h/week at baseline; Group 3: exercise >5 
h/week at age 30 and at baseline; Group 4: exercise: <1/week at age 30 and  >5 h/week at 
baseline; and Group 5: exercise 1-5 h/week at age 30 and at baseline. A statistically 
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significant association between leisure-time exercise and risk of AF was only observed 
among men who had a high level of exercise at age 30 years (>5 h/week) and became 
inactive at an older age (exercise <1 h/week at baseline) (Group 2). This group had a RR of 
1.49 (95% CI: 1.14-1.95) to develop AF compared with Group 1 (exercise <1 h/week at age 
30 and at baseline).  
Table 5. Age-standardized baseline characteristics for the lowest and highest categories of 
leisure-time exercise and walking/bicycling in the cohort of Swedish men 
Characteristic Exercise at age 
30 
 Exercise at 
baseline 
 Walking/bicycling at 
age 30 
 Walking/bicycling at 
baseline 
 <1 
h/wk 
>5 
h/wk 
 <1 
h/wk 
>5 
h/wk 
 Almost 
never 
>1 
h/day 
 Almost 
never 
>1 
h/day 
Age, mean 
(years) 
57.1 60.9  57.9 63.6  55.9 62.8  59.9 62.8 
Height, mean 
(cm) 
177 178  177 177  177 177  177 177 
BMI, mean 
(kg/m2) 
25.9 25.9  26.3 26.2  26.1 25.9  26.5 25.5 
Post-secondary 
education (%) 
13.2 14.7  13.7 10.7  14.8 12.7  14.2 12.5 
Current 
smoking (%) 
27.5 23.9  30.8 23.2  29.6 25.8  32.7 25.0 
Aspirin use (%) 36.9 35.0  37.5 34.1  37.2 35.8  38.4 34.4 
History of 
CHD or heart 
failure (%) 
8.1 8.9  9.4 8.5  10.0 8.9  10.7 8.2 
History of 
hypertension 
(%) 
24.0 21.5  26.2 22.0  26.1 23.6  27.8 21.6 
History of type 
2 diabetes (%) 
9.7 7.8  10.8 8.4  10.8 8.7  12.0 8.2 
Family history 
of MI (%) 
14.0 15.7  14.9 18.2  15.6 15.3  15.6 15.1 
Alcohol intake, 
mean (g/day) 
9.8 10.7  10.2 10.8  10.4 10.1  10.7 9.9 
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Table 6. Relative risks of AF by leisure-time exercise and walking/bicycling at age 30 
years and at baseline. 
Variable Cases* Person-
years 
Age-adjusted RR Multivariable RR†  Multivariable 
RR†,‡ 
Exercise at age 30 years (h/wk)      
<1  499 69,469 1.00 (reference) 1.00 (reference) 1.00 (reference) 
1 695 83,297 1.06 (0.94-1.19) 1.07 (0.95-1.20) 1.08 (0.95-1.22) 
2-3 1,267 140,057 1.02 (0.92-1.14) 1.04 (0.93-1.16) 1.06 (0.94-1.20) 
4-5 619 63,208 1.07 (0.95-1.20) 1.09 (0.96-1.23) 1.13 (0.98-1.29) 
>5 790 70,719 1.15 (1.02-1.29) 1.17 (1.03-1.32) 1.19 (1.05-1.36) 
P for trend   0.11 0.01 0.008 
Exercise at baseline (h/wk)      
<1  821 97,499 1.00 (reference) 1.00 (reference) 1.00 (reference) 
1 740 86,712 0.92 (0.83-1.02) 0.96 (0.86-1.06) 0.98 (0·87-1.10) 
2-3 1,369 140,318 0.90 (0.83-0.98) 0.97 (0.89-1.07) 1.01 (0·91-1.12) 
4-5 582 55,875 0.83 (0.75-0.93) 0.91 (0.81-1.02) 0.96 (0·84-1.09) 
>5 802 64,638 0.90 (0.81-0.99) 1.00 (0.90-1.12) 1.05 (0.92-1.18) 
P for trend   0.01 0.76 0.60 
Walking/bicycling at age 30 years      
Almost never  259 38,662 1.00 (reference) 1.00 (reference) 1.00 (reference) 
<20 min/day 717 96,153 1.02 (0.89-1.18) 1.03 (0.89-1.19) 1.08 (0.92-1.26) 
20-40 min/day 1,151 134,281 0.93 (0.81-1.07) 0.96 (0.84-1.10) 0.98 (0.84-1.15) 
40-60 min/day 786 76,069 0.98 (0.85-1.13) 0.99 (0.86-1.15) 1.03 (0.88-1.21) 
>1 hour/d 1,223 101,287 1.04 (0.91-1.20) 1.04 (0.90-1.20) 1.08 (0.93-1.27) 
P for trend   0.30 0.45 0.35 
Walking/bicycling at baseline      
Almost never  603 59,085 1.00 (reference) 1.00 (reference) 1.00 (reference) 
<20 min/day 1,011 112,429 0.90 (0.81-1.00) 0.96 (0.86-1.06) 0.96 (0.85-1.08) 
20-40 min/day 1,216 133,991 0.83 (0.75- 0.91) 0.89 (0.80-0.99) 0.90 (0.80-1.01) 
40-60 min/day 740 68,753 0.87 (0.78-0.97) 0.95 (0.85-1.07) 0.97 (0.86-1.11) 
>1 h/day 851 79,369 0.79 (0.71-0.87) 0.87 (0.77-0.97) 0.88 (0.77-0.998) 
P for trend   <0.0001 0.03 0.09 
*The sum does not add up to the total owing to missing data for the exposure variable.                                         
†Multivariable models were adjusted for age, education, smoking status and pack years of smoking, BMI, diabetes, history of 
hypertension, history of CHD or heart failure, family history of myocardial infarction, aspirin use, and alcohol consumption. 
Leisure-time exercise and walking/bicycling were mutually adjusted in the multivariable model.                                                                                                                                                          
‡Excluding men with previous coronary heart disease or heart failure at baseline. 
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4.3  PAPER III: PHYSICAL ACTIVITY AND THE RISK OF AF IN WOMEN 
During a median follow-up of 12 years (10th percentile 7.5 years; 90th percentile 12.0 years, 
402,369 person-years), 2,915 cases of AF were diagnosed in the cohort, which corresponds to 
7.2 cases of AF per 1,000 person-years. The baseline characteristics of the study population 
according to leisure-time exercise and walking/bicycling are presented in table 7. 
*Age-standardized to the age distribution of the study population at study entry. 
There was no association between risk of AF and leisure-time exercise or walking/bicycling 
at age 30 years. The risk of AF was inversely associated with leisure-time exercise at baseline 
with a trend from lowest to highest category, but only women in the highest category (≥4 
h/week) had a statistically significant risk reduction (RR 0.85; 95% CI: 0.75 to 0.95) 
compared with women in the lowest category (<1 h/week) (Table 8).  Walking/bicycling at 
Table 7. Baseline characteristics* of participants of the Swedish Mammography Cohort by 
categories of exercise and walking/bicycling at study entry 
 Exercise at study entry (h/wk)  Walking/bicycling at study entry (min/d) 
Characteristics <1  1 2-3 ≥4  Almost 
never 
<20 20-39 ≥40 
Age, mean (years) 61.1 60.3 61.2 62.6  64.0 60.5 60.8 62.0 
Height (cm) 164.7 164.8 164.9 164.6  164.2 164.8 165.0 164.6 
BMI, mean (kg/m2) 25.7 25.3 24.9 24.4  26.1 25.5 24.9 24.6 
Post-secondary education 
(%) 
18.1 20.2 20.3 17.9  14.9 19.0 21.2 18.1 
Current smoking (%) 29.7 23.2 20.2 22.2  32.1 25.1 21.4 22.0 
History of hypertension 
(%) 
23.4 21.9 20.4 19.1  25.5 21.8 20.5 19.4 
History of type 2 diabetes 
(%) 
4.9 3.9 3.7 4.2  6.5 4.3 3.6 3.9 
History of CHD or heart 
failure (%) 
5.6 4.7 3.9 3.7  6.9 5.0 4.0 3.7 
Family history of MI(%) 17.4 17.2 16.5 18.0  19.3 17.8 17.3 16.5 
Alcohol intake, mean 
(g/day) 
5.4 5.3 5.3 5.5  5.4 5.3 5.5 5.3 
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baseline was also inversely associated with risk of AF. Compared with women who almost 
never walked or bicycled, women who walked or bicycled 20-39 min/day and ≥40 min/day 
had a 14% and 19% lower risk of AF, respectively. The association between 
walking/bicycling and leisure-time exercise at baseline was not modified by previous CHD or 
heart failure (P for interaction walking/bicycling = 0.60 and P for interaction leisure-time 
exercise = 0.39). 
Table 8. Relative risk (95% confidence interval) of atrial fibrillation by categories of 
exercise and walking/bicycling in the Swedish Mammography Cohort, 1998–2009 
 Cases* Age-adjusted RR Multivariable RR†  
Exercise at baseline (h/week)     
<1  555 1.00 (reference) 1.00 (reference)  
1  564 0.85 (0.75-0.95) 0.89 (0.79-1.00)  
23  888 0.84 (0.75-0.93) 0.92 (0.82-1.02)  
≥4  601 0.75 (0.67-0.84) 0.85 (0.75-0.95)  
P for trend  <0.0001 0.02  
Walking/bicycling at baseline 
(min/day) 
    
     Almost never  421 1.00 (reference) 1.00 (reference)  
     <20  524 0.88 (0.78-1.01) 0.94 (0.82-1.07)  
2039  880 0.77 (0.68-0.89) 0.86 (0.76-0.97)  
≥40 937 0.71 (0.63-0.80) 0.81 (0.72-0.92)  
P for trend  <0.0001 0.0002  
*The sum does not add up to the total owing to missing data for the exposure variable. 
†Multivariable models were adjusted for same as table 6 except for adjustment of leisure-time 
exercise and walking/bicycling. 
4.4 PAPER IV: LIFESTYLE FACTORS AND THE RISK OF AF 
In both men and women, the risk of AF decreased in a dose–response manner with increasing 
number of healthy lifestyle factors (Table 9). Compared with men and women with no 
indicator of a healthy lifestyle, those with all four factors had a 50% (95% CI: 36% to 61%) 
lower risk of AF after adjustment for other risk factors. 
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We next examined the separate and joint association of different combinations of the four 
healthy lifestyle factors with AF risk (Figure. 7). Low BMI, regular walking/bicycling, and 
light or no alcohol consumption was associated with a statistically significant reduced risk of 
AF, with the most pronounced reduction in AF risk observed for a low BMI. Abstinence from 
smoking was not significantly associated with risk of AF. Combinations that included BMI 
conferred the greatest reduction in AF risk. 
Figure 7. Multivariable RR and 95% CI of AF according to different combinations of four 
healthy lifestyle factors 
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5 DISCUSSION 
5.1 MAIN FINDINGS AND GENERAL DISCUSSION 
The main result of this theses based on findings from two large population based Swedish 
cohort studies show that modifiable lifestyle factors influence the risk of AF. These findings 
are important in order to create better preventive programs to prevent or delay the onset of 
AF. AF has a variety of negative consequences that are described earlier in this thesis and 
prevention is of the essence. Praestat cautela quam medela (latin) (Prevention is better than 
cure) (Often attributed to Marcus Tullius Cicero; January 106 BC – 7 December 43 BC)  
Study I showed that even a moderate intake of alcohol (1-3 drinks / day) was associated with 
an increased risk. In line with previous studies we found that binge drinking further increased 
the risk for AF. The risk of developing AF persisted even after excluding the binge drinkers 
in both high and moderate alcohol consumers. The association between alcohol consumption 
and AF risk was similar in men and women. This finding was deviant from previous studies 
which have shown that women are generally more sensitive to the harmful effects of alcohol 
[29]. The overall result of alcohol as a risk factor for AF was confirmed in our dose-response 
meta-analysis of 7 studies (including our own cohort study) which showed a positive 
association, with an overall 8 % (6-10%) increase in AF risk per 1 drink/day increment in 
alcohol consumption.  
In study II and III we investigated the complex association between physical activity and risk 
of AF. Men who reported ≥5 hours of leisure-time exercise per week at age 30 had a 19 % 
increased risk of AF later in life compared with men who exercised less than 1 hour per week 
at that age. The risk of AF was even greater (RR 1.49) among men who exercised ≥5 hours 
per week at age 30 years, and were inactive at older age. On the other hand our data showed 
that low intensity physical activity like walking and bicycling was associated with a 
decreased risk of AF in both middle-aged and elderly men and women. In women, we could 
not observe any increased risk of AF in any age group with more intense physical activity 
like leisure-time exercise. Contrary, we found a small risk reduction in middle-age and 
elderly women at our highest categories of leisure time exercise (>5 hours/week). Our studies 
support the theory of a more complex association between physical activity and risk of AF. 
How physical activity influence the risk depends on several factors. Some of these factors 
include intensity of physical activity, duration of physical activity, age at physical activity 
measurement and possibly gender. The conflicting results in previous studies may depend on 
the fact that these factors have not been separated. Athletes and young to middle-aged men 
with a history of high levels of vigorous physical activity have an increased risk of AF [24, 
48-50, 102, 103].  On the other hand, studies done on individuals of older age showed that 
physical activity reduced or had no effect on the incidence of AF[52, 104]. Women have been 
far less studied and most studies on athletes have included exclusively men or a smaller 
portion of women. Azerbal et al reported that physical activity decreased the risk of AF 
among middle age and elderly women [105]. Everett et al and Thelle et al studied middle-
aged women from the general population and did not find any association between physical 
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activity and the increased risk of AF, instead there was a tendency for a small risk reduction 
[106, 107]. Andersen et al and Myrstad at el tried to determine if endurance exercise 
influence the risk of AF in women. They found no significant associations but the point 
estimate suggested that high levels of endurance exercise increase the risk of AF but both 
studies had limited number of end-points which decreased the power of the studies and 
resulted in a very wide CI [102, 108].  Wilhelm et al observed a sex difference for atrial and 
ventricular remodeling and autonomic tone with respect to endurance training. After a 
comparable amount of exercise, male athletes have more structural remodeling with left atrial 
dilation, larger LV mass index as well as greater relative wall thickness and sympatho-vagal 
balance [109]. All these factors could influence the risk of developing AF. Endurance sports 
were not too long ago considered inappropriate for women and they were not allowed to 
participate in endurance sport events. The first woman to run Boston Marathon was Bobby 
Gibb in 1966 and she had to wear a hooded sweatshirt in order to sneak into the race. The 
first women marathon race in the Olympic Games was held in 1984. Long-distance running 
has become popular among women just in the last one to two decades. There are still far 
fewer women than men who engage in high-intensity endurance training. Only a small 
fraction of men who engaged in high intensity endurance training over a prolonged period of 
time developed AF. In our study on men (study II) the population attributable risk for the 
exposure, lesiure-time exersice, was 1.7%. Studies have shown that 10-30 years of 
accumulated vigorous physical activity is needed to increase the risk of AF [110, 111]. Since 
AF is most likely to develop after extended periods of vigorous physical activity and years 
after the exposure we may not yet be able to identify any increased risk of AF among women 
due to insufficient follow-up time, low number of adequately exposed individuals leading to 
low number of end-points.  
Our studies together with previous studies suggest a U-shaped relationship between physical 
activity and the risk of AF in men [112]. However, there are no data to indicate that this 
would lead to premature death in this group. If there is any true gender difference between the 
association of AF and physical activity it remains unresolved.   
Finally, we investigated the combined impact of four healthy lifestyle factors (BMI <25 
kg/m2, regular walking/bicycling ≥20 min/day, no or light alcohol consumption and no 
smoking) on risk of AF.  A combination of all four healthy lifestyle factors was associated 
with a halving of the risk of AF. In this study the modifiable life style factor that was most 
strongly associated with a risk reduction was a BMI of less than 25 kg/m2. We observed no 
statistical significant association between smoking and risk of AF. AF is associated with an 
up to fivefold increased risk of stroke, it is associated with increased mortality and is one of 
the most common reasons for hospital admission [113, 114]. In view of the severe 
consequences of AF and significant economic burden that it inflicts on society it is important 
to prevent the onset of AF. The result of this study highlights the great potentials of 
preventive medicine and it is in agreement with previous studies. The ARIC study, which 
compared participants with optimal and borderline risk factors with participants with elevated 
risk factors for AF saw that the RRs (95% CI) of AF for those with borderline and optimal 
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risk profiles were 0.50 (0.44–0.57) and 0.33 (0.23–0.47), respectively, compared to those 
with an elevated risk profile. An optimal risk profile was defined as no history of cardiac 
disease; systolic blood pressure <120 mmHg, diastolic blood pressure <80 mmHg, and no use 
of antihypertensive medication; fasting serum glucose <100 mg/dL, no use of anti-diabetic 
medication, and no history of DM, BMI <25 kg/m2 and never smoker [115]. The 
Framingham Heart Study reported that prevalent coronary heart disease, hypertension, DM, 
and smoking could explain 44% of the burden of AF in men and 58% of the burden in 
women [57]. In the ARREST-AF trial an aggressive risk factor modification on multiple risk 
factors reduced the risk of recurrent AF after catheter ablation [69].  
5.2 METHODOLOGY 
All the studies in this thesis are prospective population cohort studies. Cohort studies are 
observational studies and in general they are hypothesis-generating and describe association 
between exposure and disease and not the cause of the disease. However, if properly 
conducted several cohort studies and meta-analysis combined could suggest causal 
relationship between exposure and outcome. 
5.2.1 Information bias 
Misclassification of exposure 
Measurements of the exposure variables; alcohol consumption, physical activity, BMI 
(weight and height) and smoking were self-reported in a questionnaire and some of the 
information like physical activity at age 15 and 30 was reported retrospectively at baseline in 
1997 were the participates had a mean age of 60 years. A limitation of information gathered 
by self-reported questionnaire is that the participants do not recall the exact level of the 
exposure for example leisure-time exercise. They could overestimate or underestimate the 
true level. This could lead to misclassification of exposure because of incorrect recall and 
reporting. Measurements of leisure-time exercise and walking/bicycling were done in the 
questionnaire with pre-defined categories and it is not a precise and objective measurement 
rather more an activity-ranking. The participants should however be able to classify 
themselves with rather good precision between the lowest and highest categories (<1 
hour/week vs. >5 hour/week) even when asked to do that retrospectively.  Another limitation 
and potential misclassification was that exposures of interest were only measured once and 
this could lead to measurement errors if participants changed their lifestyle during follow-up. 
Because information on exposures was gathered before diagnosis of AF, any 
misclassification would be expected to be unrelated to the outcome. Non-differential 
misclassification would most likely have attenuated rather than exaggerated the true 
association between exposure and AF in our studies.  
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Misclassification of outcome 
In all studies in this thesis, outcome of AF was collected by computerized linkage of the two 
cohorts (COSM and SMC) to the Swedish NPR which allowed for an almost complete 
follow-up. The incidence of AF may be underestimated because the cases in the Swedish 
NPR are gathered from in-hospital specialist care and from 2001 also from out-hospital 
specialist care. We cannot rule out that some of the non-cases had asymptomatic AF that was 
not diagnosed since there is no screening program in Sweden for detection of AF in 
asymptomatic patients. We have no reason to believe that different exposures of physical 
activity or alcohol should influence if the AF episode is symptomatic or not. The 
misclassification of outcome should therefore be non-differential.  
5.2.2 Selection bias 
Selection bias is limited in a prospective cohort study since exposed and unexposed 
participants should be free of the outcome off interest at start of follow-up. We cannot 
exclude the presence of selection bias since our results are based on questionnaires and the 
volunteers answering the questionnaire may not represent a cross-section of women and men 
in Sweden. Since AF could have been present but not diagnosed at start of follow-up we did a 
sensitivity analysis where we excluded AF cases during the first 3 and 5 years of follow-up in 
study IV and during the first year in study II.  The result remained essentially the same.  
Selection bias could also have occurred if there is a difference in the completeness of follow-
up between exposed and un-exposed individuals. Since follow-up of all individuals was 
through the Swedish NPR it allowed for an almost complete and equal follow-up, it is 
unlikely that the health seeking behavior is different among exposed and unexposed but we 
cannot rule it out and that could create a selection bias.  
5.2.3 Confounding 
In the four studies, we attempted to control for confounding by adjusting for other risk 
factors. In addition, we excluded participants with prior CHD or heart failure since they may 
have changed their physical activity levels and CHD and heart failure influence the risk of 
AF. Unmeasured confounding cannot be excluded and may have contributed to the observed 
results. We did not have information about obstructive sleep apnea or chronic obstructive 
pulmonary disease which could both affect the physical activity levels and the risk of AF. 
5.2.4 Publication bias 
Publication bias means that there is a tendency for small studies with negative results to 
remain unpublished. This type of bias may be introduced if only results from published 
studies are used in the meta-analysis. The presence of publication bias can be assessed by a 
variety of graphical and statistical methods. In study IV we used Egger’s test [116]. We found 
no evidence of publication bias but test for publication bias have low statistical power, 
especially when the number of studies are small (n<10). 
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6 CONCLUSION 
 
1. Alcohol consumption is associated with a increased risk of AF.  Moderate 
consumption of alcohol, which seems to lowers the risk of other cardiovascular 
diseases, was enough to slightly increase the risk of AF. 
 
2. High levels of vigorous intensity physical activity at younger age  increase the risk of 
AF in men while more moderate intensity decreases the risk at least in older men. 
 
3. Regular physical activity is associated with a reduced risk of AF in women. Moderate 
amount of daily physical activity was sufficient to have a significant risk reduction. 
High levels of leisure-time exercise were not a risk factor for AF in women as 
previously described in men. 
 
4. A combination of four healthy lifestyle factors (BMI <25 kg/m2, regular walking or 
bicycling ≥20 min/day, no or light alcohol consumption and no smoking) was 
associated with a halving of the risk of AF. The modifiable life style factor that was 
most strongly associated with a risk reduction was a BMI of less than 25 kg/m2.  
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7 FUTURE PERSPECTIVES 
Regular physical activity promotes health and reduces all-cause mortality [117]. However 
some individuals who are performing long-time vigorous physical activity will develop AF. 
Individual susceptibility factors are needed to be found. Further studies are needed to 
investigate the risk of AF in female endurance athletes. So far we have not been able to 
establish any association between long-time vigorous physical activity and the risk of AF in 
females.  The question remains if it is a true gender difference or if it is just methodological 
shortcomings and lack of power in previous studies.  
Physical activity has several positive effects on several risk factors for stroke, and there is a 
question if patients with exercise-induced AF render the same stroke risk as other AF patients 
and if CHA2DS2-VASc score is best for estimating stroke risk.  
It is known from previous studies that there are ethnic differences in the cardiac adaptation to 
intense physical activity [118]. Genetic markers for increased risk of exercise-induced AF are 
not yet found and research is needed in order to localize them.  
It is still unclear what advice to give to athletes who develop AF. Detraining could reduce the 
ventricular arrhythmias in athletes [119]. In an animal model (rats) training increased the AF 
inducibility and detraining returned it to baseline levels [120]. If detraining will do the same 
thing for human athletes is still unclear and what level of physical activity is the best is also 
unknown.  
The exact mechanisms by which regular high intensity exercise promotes the development of 
AF is unclear. Mechanisms that could be contributing include atrial enlargement, 
inflammatory changes, vagal enhancement, and structural alterations in the atria. Further 
research is needed to determine the exact mechanism.  
Today we are not able to establish specific mechanisms of AF for an individual patient. 
Current catheter based ablation strategies are mainly based on the pattern of AF (paroxysmal 
vs persistent). Destruction of atrial tissue with the purpose of curing AF could lead to 
complications such as ablation induced arrhythmias.  More research is needed to identify new 
modifiers of AF and to better understand how to intervene with reversible health modifiers. 
As our knowledge about causes and pathophysiological mechanisms grows more individual 
tailored treatments will be developed and we will have better outcomes and hopefully less 
side effects. 
 
 
 
 
 
 42 
 
 
 
 
 
 
 
 
 
 
 
  43 
8 SAMMANFATTNING (SUMMARY IN SWEDISH) 
Förmaksflimmer är den vanligaste hjärtrytmrubbningen av klinisk betydelse och förekomsten 
av förmaksflimmer beräknas hos den vuxna befolkningen var omkring 3 %. Förmaksflimmer 
kan ge en mängd olika symptom samt ökar risk att dö i förtid vilket delvis kan förklaras av en 
ökad förekomst av hjärtsvikt och stroke. Det finns ett flertal riskfaktorer och medicinska 
tillstånd som förknippas med förmaksflimmer. Exempel på dessa är hög ålder, manligt kön, 
hjärtsvikt, hjärtklaffsjukdom, hjärtinfarkt, kronisk obstruktiv lungsjukdom, sömnapné, 
kronisk njursjukdom, sköldkörtelsjukdom, rökning, alkohol och fysisk aktivitetsnivå och 
genetiska faktorer. En del riskfaktorer är modifierbara. Syftet med denna avhandling var att 
undersöka hur modifierbara livsstilsfaktorer, och då särskild alkoholkonsumtion och fysisk 
aktivitet, påverkar risken för förmaksflimmer. 
I studie I undersökte vi sambandet mellan alkoholkonsumtion och risken för förmaksflimmer 
i en prospektiv kohortstudie av svenska män och kvinnor (n = 79 019).  Vid gjorde även en 
meta-analys av tidigare genomförda prospektiva studier (n = 7). Studien visade att 
alkoholkonsumtionen är förknippat med en ökad risk för förmaksflimmer hos både män och 
kvinnor. Även måttligt intag, vilket anses minskar risken för andra hjärt-kärlsjukdom, var 
förknippat med en ökad risk för förmaksflimmer. 
I studie II undersökte vi sambandet mellan fysisk aktivitet vid olika åldrar och av olika typ 
med risk för förmaksflimmer i en stor (n = 48 850) manliga kohort. En hög nivå av motion 
(måttlig intensiv till högintensiv fysisk aktivitet) hos yngre män var förknippad med en ökad 
risk för förmaksflimmer. Däremot var promenader/cykling (låg intensiv till måttlig intensiv 
fysisk aktivitet) vid en högre ålder, förknippat med en minskad risk. 
I studie III utvärderade vi sambandet mellan fysisk aktivitet vid olika åldrar och av olika typ 
med risk att utveckla förmaksflimmer i en stor (n = 39 227) kvinnliga kohort. Regelbunden 
fysisk aktivitet var förknippad med en minskad risk för förmaksflimmer hos kvinnor. Måttlig 
mängd daglig fysisk aktivitet var tillräckligt för att minska risken hos medelålders och äldre 
kvinnor. Höga nivåer av motion (måttlig intensiv till högintensiv fysisk aktivitet) var till 
skillnad vad vi fann hos män inte en riskfaktor för förmaksflimmer hos kvinnor. 
I studie IV undersökte vi den gemensamma effekten av fyra modifierbara livsstilsfaktorer på 
risken att utveckla förmaksflimmer hos både män och kvinnor. En halvering av risken att 
utveckla förmaksflimmer såg hos dem som hade all fyra hälsosamma livsstilsfaktorer (BMI 
<25 kg/m2, regelbunden motion ≥20 min/dag, ingen eller lätt alkoholkonsumtion och ingen 
rökning). 
Sammanfattning: Alkoholkonsumtionen är förknippat med en ökad risk för 
förmaksflimmer. Högintensiv fysisk aktivitet kan öka risken för förmaksflimmer hos yngre 
män medan låg till måttlig intensiv fysisk aktivitet minskar risken hos både män och kvinnor. 
Höga nivåer av intensiv fysisk aktivitet var inte en riskfaktor för förmaksflimmer hos 
kvinnor. En hälsosam livsstil kan avsevärt minska risken för förmaksflimmer hos både män 
och kvinnor.  
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